ADAP ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADS

Ownership history in EverSource Wealth Advisors, LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which EverSource Wealth Advisors, LLC reported a position in ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADS (ADAP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 100 0.00% $13
% of Fund (quarterly)
← Back to EverSource Wealth Advisors, LLC Holdings